NCT07332598
Mayo Clinic Precure - Prospective Study
Enrolling by Invitation
Not specifiedAges 18+ObservationalMayo ClinicInvestigator-initiated
~100,000 participants
Updated 2026-03-16 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Build a comprehensive, multi-omics and phenotype dataset
Measured over Up to 5 years
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Konstantinos N. Lazaridis, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age ≥ 18 years
Registered Mayo Clinic patient
Able to provide informed written consent
Able to receive mail and packages within a United States (US) state
Able to collect and ship samples within a US state via FedEx for overnight delivery
Exclusion
Active hematological cancer or history of a hematological cancer
Allogeneic Bone Marrow Transplant (autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)
What this trial measures
- Build a comprehensive, multi-omics and phenotype datasetUp to 5 years